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Abstract
Background
Immunonutrition in sepsis, including n-3 poly-unsaturated fatty acids (PUFAs) or L-arginine
supplementation, is a controversial issue that has yielded a great number of studies for the
last thirty-five years, and the conclusions regarding the quantity and quality of this support
in patients are deceiving. The aim of the present experimental study is to investigate the
effects of a pretreatment with enteral nutrition enriched with n-3 PUFAs or L-arginine on vas-
cular dysfunctions, inflammation and oxidative stress during septic shock in rats.
Design
Rats were fed with enteral Peptamen1 HN (HN group), Peptamen1 AF containing n-3
PUFAs (AF group) or Peptamen1 AF enriched with L-arginine (AFA group). On day 4, peri-
tonitis by cecal ligation and puncture (CLP) was performed. Rats were resuscitated (H18)
once septic shock was established. After a 4-hour resuscitation, vessels and organs were
harvested to assess inflammation, superoxide anion, nitric oxide and prostacyclin levels.
Ex-vivo vascular reactivity was also performed.
Results
Compared to CLP-AF or CLP-HN groups, 47.6% of CLP-AFA rats died before the beginning
of hemodynamic measurements (vs. 8.0% and 20.0% respectively, p<0.05). AF and AFA
rats required significantly increased norepinephrine infusion rates to reach the mean arterial
pressure objective, compared to CLP-HN rats. Both CLP-AF and CLP-AFA reduced mesen-
teric resistance arterial contractility, decreased vascular oxidative stress, but increased NF-
κB (0.40±0.15 in CLP-AF and 0.69±0.06 in CLP-AFA vs. 0.09±0.03 in SHAM rats and 0.30
±0.06 in CLP-HN, ß-actin ratio, p<0.05) and pIκB expression (0.60±0.03 in CLP-AF and
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Conclusions
Although n-3 PUFAs or L-arginine supplementation exhibited an antioxidant effect, it wors-
ened the septic shock-induced vascular dysfunction. Furthermore, mortality was higher
after L-arginine supplementation.
Introduction
During the acute stress resulting from critical illness, the intense catabolic state impairs
immune functions and alters the inflammatory response. Nutrition may play a major role
through complex interferences with pro-inflammatory cytokine synthesis, immune cell regula-
tion and gene expression. The optimization of nutrition as a supportive treatment has thus
emerged as a major challenge in septic shock patients. A so-called “immunonutrition”, making
profit of the immune-regulatory properties for example of n-3 poly-unsaturated fatty acids
(PUFAs) or L-arginine, may prove efficient. N-3 PUFAs modulate the activation of genes
involved in the inflammatory process in immune cells, thus reducing the production of pro-
inflammatory cytokines and reactive oxygen species, while they increase the synthesis of anti-
inflammatory cytokines, and the release of resolvins [1–3]. On the other side, arginine is the
precursor of nitric oxide (°NO), which makes it a major factor in many biological functions
such as the immune and vascular cell functions [4]. Several studies have shown that plasma
arginine levels decrease during sepsis [5–7], and this is associated with mortality [8]. Arginine
deficiency may partly account for septic shock-induced vascular dysfunction through a loss of
°NO production in the vascular wall, subsequent alteration of endothelium-dependent vasore-
laxation [9–11] and cardiovascular dysfunction [12–14]. However, the beneficial effects of argi-
nine supplementation are still debated [7]. Plasma arginine levels are reduced at the early stage
of sepsis and the use of immune enhancing diets containing L-arginine was reported to be ben-
eficial in less severe septic patients [15], while deleterious in advanced stages of septic shock
[16,17]. A randomized multicenter clinical trial showed that enteral immunonutrition with L-
arginine, n-3 PUFAs and micronutrients, increased mortality compared to parenteral nutrition
[16]. In this latter study however L-arginine supplementation was not very high. There are few
clinical studies in which the diet was solely enriched with L-arginine: in medical intensive care
units (ICUs) with low °NO production, an arginine enriched diet tended to improve the SOFA
score and no harm effect was noticed [18]. Actually, there is evidence that L-arginine, n-3
PUFAs and anti-oxidants present in large amounts may detrimentally interact [19,20], but
there is no evidence that L-arginine is the culprit [21]. Even more so, various animal studies
have shown the benefits of arginine supplementation on immunity [22–24]. However, the data
are scarce in septic shock models and there is no study on the exclusive L-arginine supplemen-
tation during septic shock in humans.
Overall, the results of recent immunonutrition studies in ICU patients remain disappointing
[25], providing conflicting data on optimal nutrition in septic shock patients [26–30] and leav-
ing many questions unresolved. Eventually, while some studies reported that enteral supple-
mentation with eicosapentaenoic acid, gamma linolenic acid and antioxidants decreased the
mortality rate as well as mechanical ventilation and ICU stay lengths [31], other studies only
found a lower incidence of nosocomial pneumonia and organ dysfunction.
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The aim of our work was to assess the effects of different nutrition formulations containing
n-3 PUFAs and/or L-arginine in a septic shock model in rats.
Material and Methods
Animals
The experiments were performed with the approval of the Strasbourg Regional Ethics Commit-
tee for Animal Experimentation (CREMEAS, AL/68/75/02/13).
Male Wistar rats weighing 350–450 g from Janvier Labs (Le Genest-Saint-Isle, France) were
used. Before the study protocol, the animals were housed separately in temperature and humid-
ity-controlled quarters with constant 12-hour light, 12-hour dark cycles, were provided with
standard food (A04 diet; Safe, Villemoisson, France) and water ad libitum.
During all the experiments, humane endpoints were used. Experiments were indeed stopped
and the animal euthanized if they met one of the following criteria: signs of suffering not
immediately controlled by the anesthetic and/or analgesics injection, weight loss of more than
15% of initial weight during 5 days of experimentation. Rats were euthanized with an intrave-
nous lethal dose of Pentothal (100 mg/kg).
After each anesthesia and surgery, rats are observed until complete awakening, to check
there were no sign of shock (ample/depressed respiratory rate and irregular heart rhythm),
stress and pain. Pain was then assessed several times a day and if necessary, analgesics injection
was performed. The following criteria were sought for the duration of the experiment: 1. Physi-
ological signs: tachycardia, increased respiratory rate; 2. Behavioral signs: defense/escape at
manipulation; 3. Appearance: bristling hair, dull, unusual posture.
There was no unexpected death during the experiments.
Animal suffering and distress was minimized after each surgery as described below in this
section, by administering analgesics and anesthetics: anesthesia with isoflurane 1–2% (Baxter
S.A.S, Maurepas, France); analgesia with subcutaneous sufentanil (Mylan, Pittsburgh PA,
USA) (0.1 μg/kg of body weight); subcutaneous injection of 0.1 mL lidocaine 1% (AstraZeneca,
Rueil-Malmaison, France) before skin incision.
Enteral Nutrition
The following are the products for enteral nutrition used in the protocol:
- Peptamen1HN ("HN"), which is a high nitrogen peptide-based diet enteral formulation,
recommended for stress patients
- Peptamen1 AF (further referred to as "AF"), which is a formulation containing n-3
PUFAs; the product was enriched with an isonitrogenous mixture of non-essential amino
acids (4 g nitrogen/L)
- Peptamen1 AF enriched with 1.3 g/100 mL of L-arginine (further referred to as "AFA")
plus the isonitrogenous mixture of non-essential amino acids (4 g nitrogen/L).
These products were from Nestlé (France), apart from the L-arginine provided by Sigma-
Aldrich (Saint-Quentin Fallavier, France).
Study Protocol (see Fig 1)
After 8 days of acclimation, the rats were fed with different enteral nutrition products during
three days before they underwent peritonitis by cecal ligation and puncture (CLP) so as to
mimic post-surgical septic shock in patients, and then compared to SHAM rats. Briefly, rats
“Immunonutrition” and Septic Shock
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underwent a gastrostomy for enteral feeding under anesthesia. During surgical procedures, rats
were anesthetized with isoflurane 1–2% (Baxter S.A.S, Maurepas, France) and analgesia was
performed with subcutaneous sufentanil (Mylan, Pittsburgh PA, USA) (0.1 μg/kg of body
weight). A subcutaneous injection of 0.1 mL lidocaine 1% (AstraZeneca, Rueil-Malmaison,
France) was performed before skin incision. Following left-sided laparotomy, the greater cur-
vature of the stomach was isolated. A silicon catheter was placed inside the stomach and
secured by a purse-string suture. The catheter was tunneled subcutaneously to the neck, and
attached to a spring coil-swivel mechanism. The laparotomy was closed and the animals were
housed in their cages. The rats were then randomly allocated to one of the following groups:
SHAM-HN (further referred to as “SHAM” group), CLP-HN, CLP-AF and CLP-AFA. The
allocated enteral nutrition (HN, AF, AFA) was administered at identical rates during 4 days,
providing 290 kcal/kg/day and 3 g nitrogen/kg/day. Enteral nutrition was not discontinued
until rats were sacrificed at the end of the 4th day.
Cecal Ligation and Puncture Model
On the 4th day (after 72 hours of enteral nutrition), CLP rats underwent cecal ligation and
puncture as previously described [32]. The operator was blinded concerning the allocated
enteral nutrition. Rats were anesthetized as described above. A 3-cm midline new laparotomy
was performed to allow exposure, ligation and puncture of the caecum with an 18-gauge nee-
dle. A small amount of feces was extruded, the caecum was returned into the peritoneal cavity
and the laparotomy was closed. All rats received a subcutaneous injection of 0,9% NaCl (30
mL/kg body weight). The rats developed septic shock within the 16–20 hours after CLP.
SHAM rats underwent a midline laparotomy and cecal exposure without further manipulation.
After 18 hours, when CLP rats fulfilled illness criteria (lethargy, piloerection, glassy eyes), all
rats were anesthetized, tracheotomized and mechanically ventilated.
The left femoral artery was used to measure mean arterial pressure (MAP) and heart rate
(HR) and to collect blood samples. For the CLP group, septic shock was established when the
Fig 1. Protocol design.Gastrostomy was performed on day 1 (D1). Rats were then fed with different enteral nutrition products (Peptamen1 HN–“HN”,
Peptamen1 AF–“AF”, Peptamen1 AF enriched with arginine–“AFA”) for three days (72 hours) before undergoing peritonitis by cecal ligation and puncture
(CLP) or SHAM operation on day 4. Septic shock developed within 18 hours after surgery in the CLP group. Therefore from H18 to H22 after SHAM/CLP
surgery, rats were resuscitated using fluid challenge and norepinephrine to target a mean arterial pressure (MAP) value over 100 mmHg. Blood, organs and
vessels were collected at the end of the monitoring.
doi:10.1371/journal.pone.0147644.g001
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MAP fell below 90 mmHg and lactate increased over 2 mmol/L. In CLP groups, fluid resuscita-
tion was performed with a bolus of 0.9% NaCl (500 μL/10 min) if the MAP was below 100
mmHg; if it remained below 100 mmHg, norepinephrine was infused and increased by step of
0.1 μg/kg/min each 10 minutes to target a MAP above 100 mmHg. After 240 minutes, rats
were sacrificed by bloodletting under deep anesthesia; vessels were collected for ex-vivo vascu-
lar reactivity and protein expression analysis and electron paramagnetic resonance
measurements.
Vascular Reactivity
Mesenteric and aortic ring vascular reactivity was studied on a wire myograph (Danish Myo
Technology, Arhus, Denmark) as previously described [33]. Arteries were bathed in a physio-
logical salt solution (PSS: 119 mMNaCl, 4.7 mM KCl, 14.9 mM NaHCO3, 1.2 mM
MgSO4.7H2O, 2.5 mM CaCl2, 1.18 mM KH2PO4, and 5.5 mM glucose under a pH 7.4, PO2 160
mmHg, PCO2 37 mmHg) continuously bubbled with 95% O2 and 5% CO2. After an equilibra-
tion period of at least 20 min. under the optimal passive tension, two successive contractions in
response to the combination of KCl (100 mM) depolarization and serotonin (5-HT; 10 μM)
(Sigma-Aldrich) were used to test the maximal contractile capacity of the vessels. After wash-
ing, the endothelial function was assessed by testing the relaxing effect of acetylcholine (Ach
1 μM) after precontraction by 1 μM 5-HT. Following a 20-min. washout period, concentra-
tion-response curves to 5-HT were elicited by a cumulative administration of the vasoconstric-
tor agonist (1 nM to 100 μM) to vessels with their endothelium submitted or not to a specific
iNOS inhibitor, N-([3-(Aminomethyl)phenyl]methyl) ethanimidamide dihydrochloride
(1400W, 100 μM; Sigma-Aldrich), or a specific COX-2 inhibitor, N-(2-cyclohexyloxy-4-itro-
phenyl)methanesulfonamide (NS-398, 10 μM; Sigma-Aldrich). The inhibitor was added in the
bath 30 min. before the addition of 5-HT.
Electron Paramagnetic Resonance (EPR) Measurements
Nitric oxide. The artery samples were incubated for 30 min. in Krebs–Hepes buffer con-
taining bovine serum albumin (20.5 g/L), CaCl2 (3 mM), and arginine (0.8 mM). Sodium
diethyldithiocarbamate (DETC; 3.6 mg) and FeSO47H2O (2.25 mg) were separately dissolved
under nitrogen gas bubbling in 10-mL volumes of ice-cold Krebs–Hepes buffer. These com-
pounds were rapidly mixed to obtain a pale yellow-brown opalescent colloid Fe(DETC)2 solu-
tion (0.4 mM), which was immediately added to the organs and incubated for 45 min. at 37°C.
°NO measurement was performed on a table-top x-band spectrometer Miniscope (Magnettech,
MS200, Berlin, Germany). Recordings were made at 77°K, using a Dewar flask. Instrument set-
tings were as follows: microwave power 10 mW, amplitude modulation 1 mT, modulation fre-
quency 100 kHz, Sweep time 60 seconds and scan sequencing on 5.
Superoxide anion. The artery samples were allowed to equilibrate in a deferoxamine-che-
lated Krebs–Hepes solution containing 1 hydroxy-3 methoxycarbonyl 2,2,5,5-tetramethylpyr-
rolidin (CMH, Noxygen, Germany) (500 μM), deferoxamine (25 μM), and DETC (5 μM)
under constant temperature (37°C) for 1 hour. The reaction was stopped by freezing the sam-
ples in liquid nitrogen for EPR spectroscopy analysis. Values were expressed as arbitrary units
per milligram weight of dried tissue (A/Wd).
Protein Expression
Phosphorylated I kappa B-alpha (pIκB-α), nuclear factor-kappa B (NF-κB), inducible °NO
synthase (iNOS) and cyclo-oxygenases-2 (COX-2) expressions were evaluated in aorta lysates
using Western blot. Proteins were separated by electrophoresis in a 10% polyacrylamide gel
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and transferred onto a PVDF (PolyVinyliDene Fluoride) membrane. Nonspecific binding sites
were blocked with 5% skimmed milk in a Tris-Buffered Saline solution with 0.5% Tween for 1
hour at room temperature. Membranes were then incubated overnight at 4°C with primary
antibodies directed against pIκB-α (1/500, Euromedex, Souffelweyersheim, France), NF-κB
p65 (1/1,000, Ozyme, Saint Quentin, France), COX-2 (1/1,000 Cayman Chemical Co, Ann
Arbor, MI), iNOS (1/1,000, Beckton Dickinson), and β-tubulin (1/10,000, Santa Cruz Biotech-
nology, Heidelberg, Germany). After 3 washes, the membranes were incubated with secondary
antibodies (1/5,000 dilution except for anti-β-tubulin that revealed with a 1/40,000 dilution of
anti-mouse IgG) for 1 hour at room temperature and signals were revealed by chemolumines-
cence. The optical density was quantified and expressed relative to β-tubulin (image J).
Determination of Prostacyclin Production
Prostacyclin (PGI2) was measured in the incubation media of arteries harvested from the
SHAM, CLP-HN, CLP-AF and CLP-AFA groups, using an ELISA assay kit (Cayman Chemi-
cals, Montluçon, France). The concentrations of free PGI2 were expressed in pg/mg of vessel
dry weight.
Statistical Analysis
Mortality was expressed by the Kaplan Meier method and compared with the log-rank test.
The inter-group comparison of hemodynamic parameters was performed by ANOVA for
repeated measures; the pairwise comparison was made using a Tukey-Kramer adjustment for p
values. A nonparametric analysis by a Kruskal Wallis test with a Dunn post hoc test was used
for protein, °NO, O2°
- and prostacyclin analysis. All statistics was performed with Statview™
software (version 5.0, SAS Institute, Cary, NC, USA). All values were presented as mean ± SD
for n experiments, with n representing the number of rats. A p value< 0.05 was considered sta-
tistically significant.
Results
L-Arginine Supplementation Increased Septic Shock-Induced Mortality
All rats survived during the three-day enteral nutrition after gastrostomy was performed and
they did not loose weight. Compared to SHAM rats, all CLP rats were in septic shock 18 hours
after peritonitis, as defined above, with norepinephrine infusion requirement and a significant
increased plasma lactate level (p<0.05) (Table 1). Compared to CLP-AF and CLP-HN groups,
mortality was significantly higher in the CLP-AFA group after peritonitis (p<0.05; Fig 2, S1
Table). Because of an early unexpected mortality in CLP-AF and CLP-AFA groups, after CLP
surgery but before hemodynamic measurements (<18th hour), the number of rat has been
increased in these 2 groups in order to keep the same number of rats in the 4 groups for hemo-
dynamic measurements (Table 2).
PUFA and L-Arginine Supplementations Failed to Improve Septic
Shock-Induced Hemodynamic Dysfunction
Mean arterial pressure was successfully maintained at control level since it showed no differ-
ence between SHAM and CLP groups (HN, AF, AFA). However, PUFA and L-arginine supple-
mentation significantly increased norepinephrine requirements to reach the targeted MAP,
compared to SHAM and CLP-HN groups (85.0 ± 20.2 μg in CLP-AF and 104.0 ± 20.0 μg
CLP-AFA groups versus 46.0 ± 4.4 μg in CLP-HN and 9.0 ± 1.1 μg in SHAM groups, p<0.05;
Fig 3A).
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5-HT induced a concentration-dependent increase in the contraction of mesenteric arteries
rings (Fig 3B, S2 Table). Compared to the SHAM group, the vascular responses to 5-HT were
significantly decreased both in the aortic rings (not shown) and mesenteric arteries harvested
from the CLP-AF and CLP-AFA groups, but not in the CLP-HN group (Fig 3B, S2 Table).
In order to investigate the mechanisms involved in this vascular hyporeactivity, the role of
°NO and eicosanoids in 5-HT-dependent contraction was evaluated by testing the effect of
1400W and NS-398 respectively. iNOS specific inhibition did not modify the contractile
Table 1. Characteristics of septic and control rats: clinical records from the onset of septic shock to the end of the experiment and effects of differ-
ent enteral nutrition formulations.
SHAM (n = 5) CLP-HN (n = 12) CLP-AF (n = 15) CLP-AFA (n = 21)
Body Weight (g) 428 ± 28 389 ± 30 390 ± 22 379 ± 25
MAP (mmHg)
Baseline 123 ± 14 78 ± 9* 80 ± 9* 75 ± 9*
End of experiment 103 ± 19 88 ± 8 91 ± 7 97 ± 8
HR (bpm)
Baseline 338 ± 57 344 ± 22 351 ± 13 339 ± 11
End of experiment 306 ± 54 381 ± 25 349 ± 19 362 ± 19
CBF (mL/min)
Baseline 4.8 ± 1.5 4.5 ± 0.7 6.2 ± 0.8 5.0 ± 0.5
End of experiment 3.8 ± 1.7 3.4 ± 0.5 3.2 ± 0.4 3.2 ± 0.5
Lactate (mmol/l) 1.0 ± 0.4 5.2 ± 1.1* 3.3 ± 0.4* 3.4 ± 0.4*
Septic (CLP-HN, CLP-AF, CLP-AFA) and SHAM rats were treated with different enteral nutrition formulations during 4 days. Baseline was recorded 18
hours after CLP or SHAM surgery (performed on the 4th day) and rats were monitored during 4 hours (from the 18th to the 22nd hours). MAP: mean arterial
pressure, HR: heart rate, bpm: beat per minute, CBF: carotid blood ﬂow, NE: norepinephrine. Data are expressed as mean ± SD, p<0.05: * vs. SHAM.
doi:10.1371/journal.pone.0147644.t001
Fig 2. Survival of SHAM and septic rats (CLP-HN, CLP-AF and CLP-AFA) treated with different enteral nutrition formulations: Peptamen1HN (HN),
Peptamen1AF (AF), Peptamen1 AF enriched with arginine (AFA). * p<0.05 vs. all the other groups. n = 5, 12, 15 and 21 rats in SHAM, CLP-HN,
CLP-AF and CLP-AFA groups respectively.
doi:10.1371/journal.pone.0147644.g002
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responses to 5-HT in control vessels, but significantly enhanced it in vessels from CLP rats,
whatever their enteral nutrition (Fig 3C to 3F, S2 Table). When a COX-2 inhibitor was added,
only the hyporeactivity to serotonin of arteries from CLP-AF group was significantly restored
to the level of SHAM group, compared to CLP-HN and CLP-AFA groups (Fig 3C to 3F, S2
Table).
Table 2. Because of an early important mortality after CLP surgery, but before hemodynamic measurement were started (<18th hour), the number
of rat has been increased in groups were rats died 18th hour (H18) after surgery.
Groups Number of rats/group (+ rats added to compensate deaths
<H18)
Global mortality before the end of
experiment
Timing of death
SHAM 5 0 (0%) 0
CLP-HN 12 1 (8.0%) 1 rat at H21
CLP-AF 12 (+ 3) 3 (20.0%) 3 rats < H18
CLP-AFA 12 (+ 9) 10 (47.6%) * 9 rats < H18 and 1 rat at
H21
* p < 0.05 versus CLP-HN and CLP-AF.
doi:10.1371/journal.pone.0147644.t002
Fig 3. (A-F): A) Cumulative norepinephrine dose needed to reach the mean arterial pressure (MAP) objective in SHAM and septic rats treated with
different enteral nutrition formulations: Peptamen1 AF (AF), Peptamen1 HN (HN), Peptamen1AF enriched with arginine (AFA); * p<0.05 vs.
SHAM rats, # p<0.05 vs. CLP-HN rats. n = 5 for SHAM group and n = 12 for CLP-HN, CLP-AF and CLP-AFA groups. B) Ex-vivo vascular contractility
of mesenteric resistance arteries of SHAM and septic rats in response to 5-HT, * p<0.05 vs. SHAM rats. n = 5 for SHAM group and n = 12 for
CLP-HN, CLP-AF and CLP-AFA groups. C-F) Effect of the specific iNOS inhibitor (1400W) and the specific COX-2 inhibitor (NS-398) on 5-HT-
dependent contraction in mesenteric resistance arteries in each different group of rats (C = SHAM rats, D = CLP-AF rats, E = CLP-AFA rats,
F = CLP-HN rats). § p<0.05 vs. without inhibitor. Results are expressed as mean ± SD. n = 5 for SHAM group and n = 12 for CLP-HN, CLP-AF and CLP-AFA
groups.
doi:10.1371/journal.pone.0147644.g003
“Immunonutrition” and Septic Shock
PLOS ONE | DOI:10.1371/journal.pone.0147644 January 25, 2016 8 / 15
PUFA and L-Arginine Supplementations Differentially Affect Vascular
Wall Inflammation
After cell stimulation, IκB is phosphorylated, removed and degraded, allowing free NF-κB to
induce transcription. CLP significantly increased both NF-κB expression and pIκB content in
the aorta, compared to the SHAM group, and significantly more in the CLP-AFA than in the
CLP-HN and CLP-AF groups (Fig 4A and 4B, S3 Table).
Fig 4. (A-D): A-B) NF-κB p65/RelA expression and pIκB-α content in mesenteric resistance artery (MRA) tissue homogenates from septic and
SHAM rats treated with different enteral nutrition formulations: Peptamen1 AF (AF), Peptamen1HN (HN), Peptamen1AF enriched arginine (AFA).
Densitometry images are representative of six separate blots and mean ± SD densitometry values are expressed in arbitrary units (A.U.) relative to β-tubulin
content. Different enteral nutrition formulations were as follows: Peptamen1 AF (AF), Peptamen1 HN (HN), Peptamen1 AF enriched arginine (AFA). *
p<0.05 vs. all the other groups, # p<0.05 vs. SHAM rats, & p<0.05 vs. CLP-AF rats, $ <0.05 vs. CLP-HN rats. n = 5 for SHAM group and n = 12 for CLP-HN,
CLP-AF and CLP-AFA groups.
doi:10.1371/journal.pone.0147644.g004
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Compared to SHAM rats, all groups showed a significantly higher expression of iNOS and
COX-2 (Fig 4C and 4D, S3 Table). In CLP-AF and CLP-AFA groups, COX-2 expression was
significantly higher than in CLP-HN or SHAM (Fig 4D, S3 Table) groups.
PUFA and L-Arginine Supplementations Differentially Affect Nitric
Oxide, Prostacyclin and Superoxide Anion Productions
Compared to the SHAM group, arteries °NO production was significantly higher in all CLP
groups, especially in CLP-AFA (Fig 5A, S4 Table) rats. Compared to CLP-HN rats, the two for-
mulations containing PUFAs (AF and AFA) significantly decreased superoxide anion produc-
tion in arteries from septic rats (Fig 5B, S4 Table), whereas they increased prostacyclin
production in arteries (Fig 5C, S4 Table).
Discussion
With regard to septic shock, immunonutrition has aroused the interest of clinicians for several
years. While n-3 PUFAs interfere with immune and inflammatory processes [2], the L-arginine
deficit during sepsis [7,34–36] impairs the arginine/°NO pathway, setting off a multiple organ
dysfunction syndrome leading to poor clinical outcomes in septic shock. However, there is no
clear clinical benefit in supplementing septic patients with either n-3 PUFAs and/or L-arginine
[37,38].
In the present study, we have first shown that enteral L-arginine supplementation (AFA)
was deleterious in septic rats and increased early mortality, while HN and AF formulations had
no significant effect on septic rat mortality. These results are consistent with previous experi-
mental studies. In a canine septic shock model [39], L-arginine infusion was associated with
significant worsening in shock status, renal and liver functions, and increased mortality. In
humans, there are few data on the sole L-arginine supplementation during septic shock. In his
meta-analysis, Heyland [17] concluded that immune-enhancing nutrients, compared to stan-
dard diet, may increase mortality in critically ill patients, including septic patients. Bertolini
et al. [16] later supported these conclusions, showing a significantly increased mortality (44.4%
vs. 14.3%) in patients with severe sepsis receiving immunonutrition, compared to those fed
with standard parenteral nutrition. This excess mortality was attributed to L-arginine, which
would enhance °NO production and thus worsen vascular hyporesponsiveness to vasoconstric-
tor agonists [40]. Surprisingly, supplementing enteral nutrition with n-3 PUFAs (0.8 g/L and
Fig 5. (A-C): O2°
-, NO° and PGI2 levels in the aorta from septic and SHAM rats treated with different enteral nutrition formulations: Peptamen
1AF
(AF), Peptamen1 HN (HN), Peptamen1AF enriched arginine (AFA).O2°
- and NO° levels were measured by electron paramagnetic resonance (Values
were expressed as arbitrary units per milligram weight of dried tissue (A/Wd)) and PGI2 by Elisa. Results are expressed as mean ± SD. * p<0.05 vs. all the
other groups, # p<0.05 vs. SHAM rats. n = 5 for SHAM rats and n = 12 for CLP-HN, CLP-AF and CLP-AFA groups.
doi:10.1371/journal.pone.0147644.g005
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3.6 g/L in HN and AF formulations respectively) and decreasing n-6/n-3 ratio from 6.1 in HN
to 2 in AF formulation had no benefit on septic rat survival in our septic shock model.
The excess mortality in septic rats supplemented with L-arginine in our experiments may be
due to higher vasopressor needs in this group during septic shock. Although L-arginine infu-
sion in eight patients with septic shock seemed to have little effect on hemodynamic parame-
ters [41], it induced a significant blood pressure and systemic vascular resistance index
decrease, with worsened shock status in septic animal models [39,42]. This enhanced vascular
dysfunction might be partly explained by an increase in vascular inflammation and/or oxida-
tive and nitrosative stresses, as shown by our results. In the present septic shock model, L-argi-
nine supplementation was indeed responsible for vascular pro-inflammatory and pro-
oxidative effects. These results are consistent with previously published data: in a model of
mild chronic endotoxemia in pigs, Bruins et al. [43] have shown that L-arginine infusion signif-
icantly increased whole-body °NO production; the rate of °NO production seemed related to
the level of circulating L-arginine, but that was not associated with increased organ perfusion.
This suggests that L-arginine was only responsible for minor hemodynamic effects during and
after endotoxin challenge. Moreover, like in the CLP-AFA group, we have shown that the
enteral AF formulation increased norepinephrine needs in septic rats, with increased prostacy-
clin production. Compared with the standard enteral HN product, AF is an advanced formula-
tion, mainly enriched with n-3 PUFAs, aiming at reducing pro-inflammatory processes
through the modulation of lipid mediator generation, neutrophil metabolism and cytokine
response [2]. Like medium- and long-chain triglyceride emulsions, n-3 PUFAs could modulate
the inflammation through membrane composition remodeling and subsequent microparticle
release alterations [44–46]. Moreover, several studies on hypertension have pointed out that
both EPA and DHA promote vasodilation and have an anti-hypertensive effect both in experi-
mental models and in humans, by increasing °NO production and altering eicosanoid synthesis
[47]. It was for example shown that n-3 PUFAs enhance large artery endothelium-dependent
dilation assessed in flow-mediated dilation in patients with hypercholesterolemia [48]. Our
data are consistent with in vivo studies showing that n-3 PUFA supplementation increases
PGI2 generation [49]. Beside these effects, EPA/DHA supplementation could alter the endoge-
nous eicosanoid profile by providing alternative substrates for the arachidonic metabolism by
involving the cytochrome P450 pathway. Fischer et al. have indeed shown that increasing the
n-3 PUFA intake in humans resulted in a large increase of cytochrome P450-dependent epoxy-
metabolites of EPA and DHA, showing vasorelaxing effects of n-3 PUFAs [50]. Finally, it has
been shown that EPA might inhibit the production of vasoconstrictors such as endothelin-1
in-vitro [51].
In spite of numerous experimental and clinical studies, n-3 PUFA effective potential bene-
fits in septic patients remain controversial [52]. While in some studies the mortality rate,
mechanical ventilation and ICU stay lengths are decreased in septic patients supplemented
with enteral n-3 PUFAs and antioxidants [31], a randomized multicenter clinical trial recently
reported an increased mortality in the immunonutrition group [16]. Heller et al. [53] also
showed that a parenteral fish oil emulsion increased survival while it decreased infection rates,
antimicrobial requirements and length of stay in a dose-dependent manner.However, no dif-
ference was observed in another study with regard to inflammation, mortality, length of
mechanical ventilation, in septic patients [54]. Barbosa et al. [55] and Gultekin et al. [56] fur-
ther confirmed that parenteral fish oil supplementation did not improve the mortality or global
outcome of septic patients. Based on our results and the data from the literature, one may
therefore question the rationale for n-3 PUFA supplementation during septic shock, compared
with standard enteral formulation.
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The main limitation of our study lies in the fact that we could not test the effect of an argi-
nine-free enteral diet, since there is no such diet available. Moreover, although rats were resus-
citated from septic shock onset in our experiments, they did not receive antibiotics, which
would be difficult to adapt according to sanitary condition of rat breeding.
Conclusion
In this experimental septic shock model, an immunonutrition diet enriched with L-arginine or
n-3 PUFAs failed to improve septic shock-induced hemodynamic dysfunction. Moreover, L-
arginine supplementation seems to increase septic rat mortality. The need to assess the rele-
vance of these results in septic patients, calls for further studies, and the place for so-called
immunonutrition shall be questioned.
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